<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rmt</journal-id><journal-title-group><journal-title xml:lang="ru">Общая реаниматология</journal-title><trans-title-group xml:lang="en"><trans-title>General Reanimatology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-9779</issn><issn pub-type="epub">2411-7110</issn><publisher><publisher-name>FSBI "SRIGR" RAMS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15360/1813-9779-2018-6-41-50</article-id><article-id custom-type="elpub" pub-id-type="custom">rmt-1724</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Роль мозгового нейротрофического фактора BDNF и его рецептора TrkB в устойчивости нейронов гиппокампа к ишемии-реперфузии (экспериментальное исследование)</article-title><trans-title-group xml:lang="en"><trans-title>The Contribution of Brain-Derived Neurotrophic Factor (BDNF) and its TrkB Receptor to Hippocampal Neuron Resistance to Ischemia-Reperfusion (Experimental Study)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Острова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostrova</surname><given-names>Irina V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>107031, г. Москва, ул. Петровка, д. 25, стр. 2</p></bio><bio xml:lang="en"><p>25 Petrovka Str., Bldg. 2, 107031 Moscow</p></bio><email xlink:type="simple">irinaostrova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аврущенко</surname><given-names>М. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Avrushchenko</surname><given-names>Maria Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>107031, г. Москва, ул. Петровка, д. 25, стр. 2</p></bio><bio xml:lang="en"><p>25 Petrovka Str., Bldg. 2, 107031 Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голубев</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Golubev</surname><given-names>Arkady M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>107031, г. Москва, ул. Петровка, д. 25, стр. 2</p></bio><bio xml:lang="en"><p>25 Petrovka Str., Bldg. 2, 107031 Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голубева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Golubeva</surname><given-names>Nataliya V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>107031, г. Москва, ул. Петровка, д. 25, стр. 2</p></bio><bio xml:lang="en"><p>25 Petrovka Str., Bldg. 2, 107031 Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ общей реаниматологии им. В.А. Неговского, ФНКЦ РР</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V. A. Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>26</day><month>12</month><year>2018</year></pub-date><volume>14</volume><issue>6</issue><fpage>41</fpage><lpage>50</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Острова И.В., Аврущенко М.Ш., Голубев А.М., Голубева Н.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Острова И.В., Аврущенко М.Ш., Голубев А.М., Голубева Н.В.</copyright-holder><copyright-holder xml:lang="en">Ostrova I.V., Avrushchenko M.S., Golubev A.M., Golubeva N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.reanimatology.com/rmt/article/view/1724">https://www.reanimatology.com/rmt/article/view/1724</self-uri><abstract><p>Мозговой нейротрофический фактор (BDNF) и его рецептор TrkB играют важную роль в восстановлении функции мозга при различных патологических воздействиях, включая ишемию.</p><sec><title>Цель исследования</title><p>Цель исследования: оценка содержания BDNF и его рецептора TrkB в популяциях пирамидных нейронов гиппокампа в постреанимационном периоде и выявление роли этих факторов в устойчивости нейронов к ишемии.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. У белых половозрелых крыс-самцов, перенесших 10-минутную остановку сердца, на разных сроках постреанимационного периода (1-е, 4-е, 7-е, 14-е сутки) исследовали состояние популяций пирамидных нейронов полей СА1 и СА4 гиппокампа. Контролем служили ложнооперированные животные. С помощью иммуноцитохимических методов выявляли иммунореактивность к белкам BDNF и TrkB. На основании визуальной оценки и анализа оптической плотности выделяли типы нейронов с разной интенсивностью окраски: слабой (BDNF–, TrkB–), умеренной (BDNF+, TrkB+) и сильной (BDNF++, TrkB++). Определяли общую плотность нейронов и число клеток с разной иммунореактивностью к исследуемыхм белкам на 1 мм длины. В работе использовали микроскоп Olympus BX-41, программы Image Scope М, ImageJ 1,48v, MS Excel. Статистическую обработку данных проводили в программе Statistica 7.0.</p></sec><sec><title>Результаты</title><p>Результаты. У реанимированных животных в сравнении с контролем в обоих исследованных полях гиппокампа наблюдали снижение общей плотности популяции пирамидных нейронов: в поле СА1 — на 4-е сутки после остановки сердца (на 26%), в поле СА4 — на 7-е сутки (на 38,5%). Выявили, что в поле СА4 на 4-е сутки в 2 раза возрастало число BDNF+-нейронов, а число BDNF++-нейронов снижалось. На 7-е сутки резко снижалось число BDNF–-клеток, число BDNF+-клеток уменьшалось до контрольного уровня, а число BDNF++-нейронов оставалось сниженным относительно контроля. В поле СА1 на 4-е сутки наблюдали снижение числа BDNF-- и BDNF+-клеток при сохранении числа BDNF++-нейронов. На 14-е сутки выявленные изменения сохранялись. При анализе иммунореактивности к белку TrkB в поле СА4 на 7-е сутки постреанимационного периода выявили уменьшение числа TrkB–-клеток по сравнению с контролем. К 14-м суткам было снижено число не только TrkB–-нейронов, но и TrkB+-клеток при сохранении числа TrkB++-нейронов на уровне контроля. В поле СА1 на 4-е сутки после реанимации наблюдали уменьшение числа TrkB+-нейронов, на 7-е сутки — уменьшение числа как TrkB+, так и TrkB–-нейронов. К 14-м суткам число TrkB–-нейронов оставалось сниженным. Число TrkB++-нейронов при этом сохранялось на контрольном уровне за все время наблюдения.</p></sec><sec><title>Заключение</title><p>Заключение. Полученные результаты указывают на то, что устойчивость нейронов к ишемии-реперфузии ассоциирована с содержанием в них белков BDNF и TrkB. Снижение общей плотности нейронов в постреанимационном периоде происходило как в поле СА1, так и в поле СА4 гиппокампа, при этом гибели подвергались только клетки с минимальным и умеренным содержанием исследуемых белков. Нейроны с наибольшим содержанием белков BDNF и TrkB выживали.</p></sec></abstract><trans-abstract xml:lang="en"><p>The purpose of the study: to assess the content of BDNF and its TrkB receptor in the populations of hippocampal pyramidal neurons in the post-resuscitation period and to identify the contribution of these factors to the neuron resistance to ischemia.Material and methods. The condition of populations of pyramidal neurons of the CA1 and CA4 hippocampus fields was investigated in white mature male rats that underwent a 10-minute cardiac arrest at different periods of the post-resuscitation period (1st, 4th, 7th, 14th day). Animals after a sham surgery served as a reference group. Immunocytochemical methods were used to determine immunoreactivity to BDNF and TrkB proteins. Based on the visual inspection and analysis of the optical density, the following types of neurons with different color intensity were distinguished: weak (BDNF–, TrkB–), moderate (BDNF+, TrkB+) and strong (BDNF++, TrkB++). The total density of neurons and the number of cells with different immunoreactivity to the studied proteins per 1 mm of length were determined. We used the Olympus BX-41 microscope and Image Scope M, ImageJ 1.48 v, MS Excel software. Statistical data processing was performed using Statistica 7.0 software.Results. There was a decrease in the overall density of the population of pyramidal neurons in both studied fields of the hippocampus of the resuscitated animals as compared to the reference group: in the CA1field, on the 4th day after cardiac arrest (26%); in the CA4 field, on the 7th day (38.5%). It was found that the number of BDNF+ neurons doubled in the CA4 field on the 4th day, and the number of BDNF++ neurons decreased. On the 7th day, the number of BDNF– cells decreased sharply, the number of BDNF+ cells decreased to the reference level, and the number of BDNF++ neurons remained reduced vs. the reference group. There was a decrease in the number of BDNF– and BDNF+ cells in the CA1 field on the 4th day, while the number of BDNF++ neurons remained the same. The observed changes remained on Day 14.The analysis TrkB protein expression in the CA4 field on the 7th day of the post-resuscitation period as revealed by reactivity with anti-TrkB antibody demonstrated a decrease in the number of TrkB– cells as compared to the reference group. By the 14th day, the number of not only TrkB– neurons, but also TrkB+ cells was reduced, while the number of TrkB++ neurons remained at the level of the reference group. There was a decrease in the number of TrkB+ neurons was observed in the CA1 field on the 4th day after resuscitation. On day 7, there was a decreased numbers of both TrkB+ and TrkB–-neurones. The number of TrkB–-neurones remained decreased up to day 14. At that, the number of TrkB++ neurons persisted at the reference level throughout the observation period.Conclusion. The obtained results demonstrate that the resistance of neurons to ischemia-reperfusion is associated with the intracellular expression of BDNF and TrkB proteins. The reduction of the overall density of neurons in the post-resuscitation period was obsereved both in hippocampal fields CA1 and СА4; only cells with minimal and moderate content of the studied proteins died. Neurons with the highest BDNF and TrkB protein content survived.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гиппокамп</kwd><kwd>пирамидные нейроны</kwd><kwd>поле СА1</kwd><kwd>поле СА4</kwd><kwd>остановка сердца</kwd><kwd>постреанимационный период</kwd><kwd>ишемия</kwd><kwd>иммуногистохимия</kwd><kwd>BDNF</kwd><kwd>TrkB</kwd><kwd>нейропротекция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hippocampus</kwd><kwd>pyramidal neurons</kwd><kwd>CA1 field</kwd><kwd>СА4 field</kwd><kwd>cardiac arrest</kwd><kwd>post-resuscitation period</kwd><kwd>ischemia</kwd><kwd>immunohistochemistry</kwd><kwd>BDNF</kwd><kwd>TrkB</kwd><kwd>neuroprotection</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Larpthaveesarp A., Ferriero D.M., Gonzalez F.F. Growth factors for the treatment of ischemic brain injury (growth factor treatment). Brain Sci. 2015; 5 (2): 165–177. DOI: 10.3390/brainsci5020165. PMID: 25942688</mixed-citation><mixed-citation xml:lang="en">Larpthaveesarp A., Ferriero D.M., Gonzalez F.F. Growth factors for the treatment of ischemic brain injury (growth factor treatment). Brain Sci. 2015; 5 (2): 165–177. DOI: 10.3390/brainsci5020165. PMID: 25942688</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao H., Alam A., San C.Y., Eguchi S., Chen Q., Lian Q., Ma D. Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: recent developments. Brain Res. 2017; 1665: 1–21. DOI: 10.1016/j.brainres.2017.03.029. PMID: 28396009</mixed-citation><mixed-citation xml:lang="en">Zhao H., Alam A., San C.Y., Eguchi S., Chen Q., Lian Q., Ma D. Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: recent developments. Brain Res. 2017; 1665: 1–21. DOI: 10.1016/j.brainres.2017.03.029. PMID: 28396009</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chen A., Xiong L.J., Tong Y., Mao M. The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomed. Rep. 2013; 1 (2): 167–176. DOI: 10.3892/br.2012.48. PMID: 24648914</mixed-citation><mixed-citation xml:lang="en">Chen A., Xiong L.J., Tong Y., Mao M. The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomed. Rep. 2013; 1 (2): 167–176. DOI: 10.3892/br.2012.48. PMID: 24648914</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Berretta A., Tzeng Y.C., Clarkson A.N. Post-stroke recovery: the role of activity-dependent release of brain-derived neurotrophic factor. Expert. Rev. Neurother. 2014; 14 (11): 1335–1344. DOI: 10.1586/14737175.2014.969242. PMID: 25319267</mixed-citation><mixed-citation xml:lang="en">Berretta A., Tzeng Y.C., Clarkson A.N. Post-stroke recovery: the role of activity-dependent release of brain-derived neurotrophic factor. Expert. Rev. Neurother. 2014; 14 (11): 1335–1344. DOI: 10.1586/14737175.2014.969242. PMID: 25319267</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Дмитриева В.Г., Ставчанский В.В., Поварова О.В., Скворцова В.И., Лимборская С.А., Дергунова Л.В. Влияние ишемии на экспрессию генов нейротрофинов и их рецепторов в структурах мозга крыс вне очага повреждения, включая противоположное полушарие. Молекулярная биология. 2016; 50 (5): 775–784. DOI: 10.7868/S0026898416 03006X. PMID: 27830679</mixed-citation><mixed-citation xml:lang="en">Dmitrieva V.G., Stavchansky V.V., Povarova O.V., Skvortsova V.I., Limborska S.A., Dergunova L.V. Effects of ischemia on the expression of neurotrophins and their receptors in rat brain structures outside the lesion site, including on the opposite hemisphere. Mol. Biol. (Mosk.). 2016; 50 (5): 775–784. DOI: 10.7868/S002689841603006X. PMID: 27830679. [In Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kimura A., Namekata K., Guo X., Harada C., Harada T. Neuroprotection, growth factors and BDNF-TrkB signaling in retinal degeneration. Int. J. Mol. Sci. 2016; 17 (9): pii: E1584. PMID:27657046. DOI: 10.3390/ ijms17091584. PMID: 27657046</mixed-citation><mixed-citation xml:lang="en">Kimura A., Namekata K., Guo X., Harada C., Harada T. Neuroprotection, growth factors and BDNF-TrkB signaling in retinal degeneration. Int. J. Mol. Sci. 2016; 17 (9): pii: E1584. PMID:27657046. DOI: 10.3390/ ijms17091584. PMID: 27657046</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wu C.H., Hung T.H., Chen C.C., Ke C.H., Lee C.Y., Wang P.Y., Chen S.F. Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling. PLoS One. 2014; 9 (11): e113397. DOI: 10.1371/journal.pone. 0113397. PMID: 25415296</mixed-citation><mixed-citation xml:lang="en">Wu C.H., Hung T.H., Chen C.C., Ke C.H., Lee C.Y., Wang P.Y., Chen S.F. Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling. PLoS One. 2014; 9 (11): e113397. DOI: 10.1371/journal.pone. 0113397. PMID: 25415296</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Vilar M., Mira H. Regulation of neurogenesis by neurotrophins during adulthood: expected and unexpected roles. Front Neurosci. 2016; 10: 26. DOI: 10.3389/fnins.2016.00026. PMID: 26903794</mixed-citation><mixed-citation xml:lang="en">Vilar M., Mira H. Regulation of neurogenesis by neurotrophins during adulthood: expected and unexpected roles. Front Neurosci. 2016; 10: 26. DOI: 10.3389/fnins.2016.00026. PMID: 26903794</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mokhtari T., Akbari M., Malek F., Kashani I.R., Rastegar T., Noorbakhsh F., Ghazi-Khansari M., Attari F., Hassanzadeh G. Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region. Daru. 2017; 25 (1): 4. DOI: 10.1186/s40199-017-0169-x. PMID: 28202057</mixed-citation><mixed-citation xml:lang="en">Mokhtari T., Akbari M., Malek F., Kashani I.R., Rastegar T., Noorbakhsh F., Ghazi-Khansari M., Attari F., Hassanzadeh G. Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region. Daru. 2017; 25 (1): 4. DOI: 10.1186/s40199-017-0169-x. PMID: 28202057</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Корпачев В.Г., Лысенков С.П., Тель Л.З. Моделирование клинической смерти и постреанимационной болезни у крыс. Патол. физиол. и эксперим. терапия. 1982; 26 (3): 78–80. PMID: 7122145</mixed-citation><mixed-citation xml:lang="en">Korpachev V.G., Lysenkov S.P., Tel L.Z. Modeling clinical death and postresuscitation disease in rats. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya. 1982; 26 (3): 78–80. PMID: 7122145. [In Russ.]</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tecuatl C., Herrrera-López G., Martín-Ávila A., Yin B., Weber S., Barrionuevo G., Galván E.J. TrkB-mediated activation of the phosphatidylinositol-3-kinase/Akt cascade reduces the damage inflicted by oxygen-glucose deprivation in area CA3 of the rat hippocampus. Eur. J. Neurosci. 2018; 47 (9): 1096–1109. DOI: 10.1111/ejn.13880. PMID: 29480936</mixed-citation><mixed-citation xml:lang="en">Tecuatl C., Herrrera-López G., Martín-Ávila A., Yin B., Weber S., Barrionuevo G., Galván E.J. TrkB-mediated activation of the phosphatidylinositol-3-kinase/Akt cascade reduces the damage inflicted by oxygen-glucose deprivation in area CA3 of the rat hippocampus. Eur. J. Neurosci. 2018; 47 (9): 1096–1109. DOI: 10.1111/ejn.13880. PMID: 29480936</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lee T.H., Yang J.T., Ko Y.S., Kato H., Itoyama Y., Kogure K. Influence of ischemic preconditioning on levels of nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors in hippocampus following forebrain ischemia. Brain Res. 2008; 1187: 1–11. DOI: 10.1016/j.brainres.2007.09.078. PMID: 18036511</mixed-citation><mixed-citation xml:lang="en">Lee T.H., Yang J.T., Ko Y.S., Kato H., Itoyama Y., Kogure K. Influence of ischemic preconditioning on levels of nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors in hippocampus following forebrain ischemia. Brain Res. 2008; 1187: 1–11. DOI: 10.1016/j.brainres.2007.09.078. PMID: 18036511</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Shu X., Zhang Y., Xu H., Kang K., Cai D. Brain-derived neurotrophic factor inhibits glucose intolerance after cerebral ischemia. Neural. Regen. Res. 2013; 8 (25): 2370–2378. DOI: 10.3969/j.issn.1673-5374.2013.25.008. PMID: 25206547</mixed-citation><mixed-citation xml:lang="en">Shu X., Zhang Y., Xu H., Kang K., Cai D. Brain-derived neurotrophic factor inhibits glucose intolerance after cerebral ischemia. Neural. Regen. Res. 2013; 8 (25): 2370–2378. DOI: 10.3969/j.issn.1673-5374.2013.25.008. PMID: 25206547</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Huang W., Meng F., Cao J., Liu X., Zhang J., Li M. Neuroprotective role of exogenous brain-derived neurotrophic factor in hypoxia-hypoglycemia-induced hippocampal neuron injury via regulating Trkb/MiR134 signaling. J. Mol. Neurosci. 2017; 62 (1): 35–42. DOI: 10.1007/s12031017-0907-z. PMID: 28343294</mixed-citation><mixed-citation xml:lang="en">Huang W., Meng F., Cao J., Liu X., Zhang J., Li M. Neuroprotective role of exogenous brain-derived neurotrophic factor in hypoxia-hypoglycemia-induced hippocampal neuron injury via regulating Trkb/MiR134 signaling. J. Mol. Neurosci. 2017; 62 (1): 35–42. DOI: 10.1007/s12031-017-0907-z. PMID: 28343294</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">de la Tremblaye P.B., Benoit S.M., Schock S., Plamondon H. CRHR1 exacerbates the glial inflammatory response and alters BDNF/TrkB/pCREB signaling in a rat model of global cerebral ischemia: implications for neuroprotection and cognitive recovery. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2017; 79 (Pt B): 234–248. DOI: 10.1016/j.pnpbp.2017.06.021. PMID: 28647536</mixed-citation><mixed-citation xml:lang="en">de la Tremblaye P.B., Benoit S.M., Schock S., Plamondon H. CRHR1 exacerbates the glial inflammatory response and alters BDNF/TrkB/pCREB signaling in a rat model of global cerebral ischemia: implications for neuroprotection and cognitive recovery. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2017; 79 (Pt B): 234–248. DOI: 10.1016/j.pnpbp.2017.06.021. PMID: 28647536</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrer I., López E., Pozas E., Ballabriga J., Martí E. Multiple neurotrophic signals converge in surviving CA1 neurons of the gerbil hippocampus following transient forebrain ischemia. J. Comp. Neurol. 1998; 394 (4): 416–430. DOI: 10.1002/(SICI)1096-9861(19980518)394:4&lt;416::AID-CNE2&gt;3.0.CO;2-4. PMID: 9590552</mixed-citation><mixed-citation xml:lang="en">Ferrer I., López E., Pozas E., Ballabriga J., Martí E. Multiple neurotrophic signals converge in surviving CA1 neurons of the gerbil hippocampus following transient forebrain ischemia. J. Comp. Neurol. 1998; 394 (4): 416-430. DOI: 10.1002/(SICI)1096-9861(19980518)394:4&lt;416::AID-CNE2&gt;3.0.CO;2-4. PMID: 9590552</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Liu C., Chan C.B., Ye K. 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Transl. Neurodegener. 2016; 5: 2. DOI: 10.1186/s40035-015-0048-7. PMID: 26740873</mixed-citation><mixed-citation xml:lang="en">Liu C., Chan C.B., Ye K. 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Transl. Neurodegener. 2016; 5: 2. DOI: 10.1186/s40035-015-0048-7. PMID: 26740873</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Povarnina P., Gudasheva T.A., Seredenin S.B. Dimeric dipeptide mimetics of NGF and BDNF are promising agents for post-stroke therapy. JBiSE. 2018; 11 (5): 100–107. DOI: 10.4236/jbise.2018.115009</mixed-citation><mixed-citation xml:lang="en">Povarnina P., Gudasheva T.A., Seredenin S.B. Dimeric dipeptide mimetics of NGF and BDNF are promising agents for post-stroke therapy. JBiSE. 2018; 11 (5): 100–107. DOI: 10.4236/jbise.2018.115009</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sangiovanni E., Brivio P., Dell’Agli M., Calabrese F. Botanicals as modulators of neuroplasticity: focus on BDNF. Neural. Plast. 2017; 2017: 5965371. DOI: 10.1155/2017/5965371. PMID: 29464125</mixed-citation><mixed-citation xml:lang="en">Sangiovanni E., Brivio P., Dell’Agli M., Calabrese F. Botanicals as modulators of neuroplasticity: focus on BDNF. Neural. Plast. 2017; 2017: 5965371. DOI: 10.1155/2017/5965371. PMID: 29464125</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Fahimi A., Baktir M.A., Moghadam S., Mojabi F.S., Sumanth K., McNerney M.W., Ponnusamy R., Salehi A. Physical exercise induces structural alterations in the hippo1campal astrocytes: exploring the role of BDNF-TrkB signaling. Brain Struct. Funct. 2017; 222 (4): 1797–1808. DOI: 10.1007/s00429-016-1308-8. PMID: 27686571</mixed-citation><mixed-citation xml:lang="en">Fahimi A., Baktir M.A., Moghadam S., Mojabi F.S., Sumanth K., McNerney M.W., Ponnusamy R., Salehi A. Physical exercise induces structural alterations in the hippo1campal astrocytes: exploring the role of BDNF-TrkB signaling. Brain Struct. Funct. 2017; 222 (4): 1797–1808. DOI: 10.1007/s00429-016-1308-8. PMID: 27686571</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Luo J., Zheng H., Zhang L., Zhang Q., Li L., Pei Zh., Hu X. High-frequency repetitive transcranial magnetic stimulation (rTMS) improves functional recovery by enhancing neurogenesis and activating BDNF/TrkB signaling in ischemic rats. Int. J. Mol. Sci. 2017; 18 (2): pii: E455. DOI: 10.3390/ijms18020455. PMID: 28230741</mixed-citation><mixed-citation xml:lang="en">Luo J., Zheng H., Zhang L., Zhang Q., Li L., Pei Zh., Hu X. High-frequency repetitive transcranial magnetic stimulation (rTMS) improves functional recovery by enhancing neurogenesis and activating BDNF/TrkB signaling in ischemic rats. Int. J. Mol. Sci. 2017; 18 (2): pii: E455. DOI: 10.3390/ijms18020455. PMID: 28230741</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
